SCHEMBL8620569

SCHEMBL8620569

ICCCCCCc1ccc(-c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 2/20 0.53
HDAC1 Q13547 1/20 0.53
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
ALOX12 P18054 1/20 0.50
CASP1 P29466 1/20 0.50
HSD17B10 Q99714 1/20 0.50
FFAR1 O14842 1/20 0.47
MAOB P27338 2/20 0.47
MGLL Q99685 1/20 0.46
FDFT1 P37268 2/20 0.46
SIGMAR1 Q99720 2/20 0.45
TAAR1 Q96RJ0 1/20 0.45
HSD11B1 P28845 1/20 0.45
MAOA P21397 1/20 0.43
RARB P10826 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8619956 0.91 ALDH1A1 (0.54) HDAC2HDAC1ALDH1A1HPGDALOX15
SCHEMBL8622458 0.91 ALDH1A1 (0.54) HDAC2HDAC1ALDH1A1HPGDALOX15
SCHEMBL4533203 0.89 ALDH1A1 (0.52) HDAC2HDAC1ALDH1A1HPGDALOX15
SCHEMBL6379725 0.87 ALDH1A1 (0.67) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL2112457 0.87 ALDH1A1 (0.67) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL6680538 0.87 ALDH1A1 (0.67) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL3625544 0.87 ALDH1A1 (0.67) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL282602 0.87 ALDH1A1 (0.67) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL8500856 0.87 ALDH1A1 (0.67) ALDH1A1HPGDALOX15ALOX12CASP1
SCHEMBL6683681 0.87 ALDH1A1 (0.67) ALDH1A1HPGDALOX15ALOX12CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed
EP-0595635-A1 Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors E.R. Squibb & Sons, Inc. (US) 1994-05-04 EP disclosed